Navigation Links
Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments
Date:7/10/2014

Port Washington, New York (PRWEB) July 10, 2014

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that a couple has brought a lawsuit over allegations that the woman’s hidden, aggressive leiomyosarcoma was spread through her body by a power morcellator used during a routine laparoscopic supracervical hysterectomy procedure. The lawsuit has been filed against Richard Wolf Medical Instruments Corporation over its Wolf Power Morcellator and was brought on behalf of Sarah Salem-Robinson and her husband, Alan A. Robinson, in the Northern District of California on May 13, 2014 (Case5:14-cv-02209-PSG).

Two weeks following the procedure, the woman was advised that one of her fibroids was a uterine leiomyosarcoma, which is a rare and aggressive form of hidden, or so-called “occult” cancer, according to a report dated July 9, 2014 by The Washington Post. To date, she has been diagnosed with four lesions on one lung that, according to her lawsuit, likely are metastatic leiomyosarcoma resulting from the morcellator.

Parker Waichman comments that it is aware of at least one other lawsuit brought over potential injuries suffered following the use of morcellator tools during routine medical procedures. The firm indicates that it also understands that minimally invasive gynecologic procedures in which power morcellators are used present potential, often fatal, patient danger and reduced longevity. Parker Waichman is available to assist women who have suffered injury, or the loved ones of women who have suffered injury, following these procedures. Burkhart v. LiNA Medical US et al., filed on March 14, 2014, Case No. 5:14-cv-1557, in the U.S. District Court for the Eastern District of Pennsylvania, Allentown.

The U.S. Food and Drug Administration (FDA) issued a warning on April 17, 2014 concerning the use of power morcellators during minimally invasive hysterectomies (uterine removal) or myomectomies (uterine fibroid removal), as these surgical tools may spread a hidden cancer, significantly worsening a patient's prognosis and survival. The agency explained that laparoscopic power morcellators break up pieces of tissue during surgical procedures, making the tissue more easily removable through tiny incisions made in the body. The agency communication indicated that power morcellators, when used in women who have an undetected uterine sarcoma (cancer), may spread the cancer to other parts of the body. This adversely impacts a woman’s likelihood of long-term survival. According to the FDA, at least one in 350 women who undergo a hysterectomy or a myomectomy has an unsuspected sarcoma.

“Thousands of women undergo minimally invasive surgeries for hysterectomy or uterine fibroid removal annually. These women are often unaware that use of power morcellators during their procedures may spread a hidden, aggressive tumor,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “Our firm continues to investigate cases in which power morcellators may have spread these deadly cancers.”

Following the FDA’s warning over power morcellators potentially spreading hidden cancers, Johnson & Johnson, the largest maker of these devices, announced its discontinuation of its power morcellator lines worldwide, including the “Gynecare Morcellex,” “Morcellex Sigma,” and “Gynecare X-Tract,” according to an April 29, 2014 The Wall Street Journal report. The device maker has not issued a recall of the devices. Several hospitals, including the Cleveland Clinic, have ceased using power morcellators since the FDA recommendation was issued, according to The Washington Post.

The FDA is now looking into taking additional measures, including adding a “black box” warning, the agency’s most serious safety warning, to power morcellator product labeling. An external advisory panel is scheduled to conduct a hearing on the issue this week, which is also expected to focus on the FDA’s 510(k) process, a fast-tracked route in which medical devices are released to market with little or no clinical testing and follow-up if they are found to be significantly similar to a previously approved device.; power morcellators received FDA clearance through the 510(k) route. David R. Challoner, vice president emeritus for health affairs at the University of Florida and lead author of a 2011 Institute of Medicine study criticizes the process as being flawed, saying in an interview that “the morcellation disaster is yet another tragic anecdote of the failure of 510(k),” according to The Washington Post report. “Until we have a means of pre-operatively identifying the few women with leiomyosarcoma instead of fibroids, this technology should be banned,” he added.

Parker Waichman LLP offers free legal consultations to victims of injuries allegedly caused by medical devices, including morcellator devices, and injuries allegedly suffered during fibroid removal. If you or a loved one experienced injuries during a fibroid surgery that might be associated with a morcellator device, please contact the Firm at its Power Morcellator page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Read the full story at http://www.prweb.com/releases/2014/07/prweb12010847.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. More Unmarried Couples Having Babies: CDC
2. Study examines how parenthood affects gay couples health, HIV risk
3. Decisions About Condom Use Among Gay Couples Vary by Race
4. Macho Men Do Worse in Couples When the Woman Earns More
5. UCLA-led project aimed at African American couples affected by HIV gets $2.5 million boost
6. Studying couples to improve health, better relationships
7. Couples Therapy May Help Combat PTSD
8. Couples Sexual Relationships Can Suffer During IVF, Study Finds
9. Good quality of life for couples who adopt
10. UC research explores relationship-building program for male same-sex couples
11. Queens research gives fresh hope to couples with unexplained infertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... Usually, the impending ... daily wardrobe. However, for those self-conscious about a double chin, this means more anxiety ... ideal solution. , “For most people, a double chin is undesirable,” Dr. Goldman ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical ... begin serving as new board chair for Orange County health care system CalOptima ... remainder of soon-to-be former chair Mark Refowitz’s term, which runs through June 30 ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in ... quality care can be limited while the desire to conquer breakouts and eliminate skincare ... care for every customer online, today released its inaugural survey on the State of ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... The Executives, ... to raise money to for the Toys for Tots Literacy Campaign at their Semi-Annual ... in excess of $70 billion, the U.S. ranks at number 14 internationally in literacy. ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... which will be offered by the American Association of Integrative Medicine and available ... for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , Ed ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LONDON , March 27, 2017 ... require to better understand Bayer and its partnering interests and ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ... and company data. The report will be delivered ...
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: ... it intends to offer shares of common stock in ... statement on file with the Securities and Exchange Commission ... other conditions, and there can be no assurance as ... or as to the actual size or terms of ...
(Date:3/27/2017)...  A new survey from the American ... Bidding Program (CBP) significantly reduced beneficiary choice and access ... choice forces beneficiaries to switch to unfamiliar or unsuitable ... AADE,s survey is the latest in a ... out the inherent problems with the CBP. Last year, ...
Breaking Medicine Technology: